Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $250.87 | 16 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $58.64 | 4 | $0 (2024) |
| Astellas Pharma US Inc | $29.84 | 2 | $0 (2024) |
| Merck Sharp & Dohme LLC | $26.98 | 2 | $0 (2023) |
| Novo Nordisk Inc | $25.26 | 2 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $24.39 | 1 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $22.22 | 1 | $0 (2022) |
| Harmony Biosciences LLC | $20.43 | 1 | $0 (2023) |
| Bayer HealthCare Pharmaceuticals Inc. | $15.04 | 1 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $15.00 | 1 | $0 (2023) |
| Amgen Inc. | $13.07 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $48.26 | 3 | AstraZeneca Pharmaceuticals LP ($33.76) |
| 2023 | $75.46 | 5 | Merck Sharp & Dohme LLC ($26.98) |
| 2022 | $101.89 | 6 | Janssen Pharmaceuticals, Inc ($24.39) |
| 2018 | $11.53 | 1 | Novo Nordisk Inc ($11.53) |
| 2017 | $13.73 | 1 | Novo Nordisk Inc ($13.73) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Respiratory | ||||||
| 07/30/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Biological | ||||||
| 07/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Respiratory | ||||||
| 10/05/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), VERQUVO, VERQUVO | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: NEUROSCIENCE | ||||||
| 04/12/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/05/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: Respiratory | ||||||
| 03/24/2023 | Merck Sharp & Dohme LLC | STEGLATRO (Drug), BELSOMRA, VERQUVO | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/11/2023 | Harmony Biosciences LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $20.43 | General |
| Category: SLEEP MEDICINE | ||||||
| 12/14/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Cardio-renal | ||||||
| 12/01/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: Respiratory | ||||||
| 08/17/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/06/2022 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 04/28/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Inflammation | ||||||
| 04/20/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Urology | ||||||
| 09/24/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $11.53 | General |
| Category: Diabetes | ||||||
| 11/07/2017 | Novo Nordisk Inc | Victoza (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 465 | 1,163 | $166,956 | $63,730 |
| 2022 | 11 | 489 | 1,106 | $193,638 | $71,761 |
| 2021 | 17 | 1,225 | 1,549 | $211,282 | $64,735 |
| 2020 | 12 | 491 | 723 | $151,730 | $40,793 |
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 155 | 472 | $118,000 | $40,664 | 34.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 92 | 92 | $18,430 | $11,861 | 64.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 25 | 34 | $10,200 | $4,598 | 45.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 34 | $5,950 | $2,091 | 35.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 95 | 177 | $1,416 | $1,380 | 97.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 13 | 20 | $2,900 | $1,080 | 37.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $5,100 | $869.50 | 17.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 11 | 15 | $2,980 | $786.63 | 26.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 16 | 290 | $580.00 | $239.99 | 41.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 14 | 14 | $1,400 | $160.44 | 11.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 142 | 503 | $127,736 | $46,536 | 36.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 72 | 72 | $14,435 | $9,422 | 65.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 29 | 38 | $12,044 | $4,899 | 40.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 36 | 52 | $9,186 | $3,109 | 33.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 15 | 15 | $7,500 | $2,441 | 32.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $6,800 | $2,198 | 32.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 21 | 24 | $4,653 | $1,197 | 25.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 14 | 23 | $3,480 | $1,132 | 32.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 110 | 190 | $2,949 | $561.24 | 19.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 17 | 156 | $4,296 | $138.96 | 3.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 13 | 13 | $559.00 | $126.23 | 22.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 108 | 251 | $72,184 | $22,238 | 30.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 86 | 120 | $46,497 | $15,437 | 33.2% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 88 | 88 | $7,386 | $5,739 | 77.7% |
| 0001A | Adm sarscov2 30mcg/0.3ml 1st | Office | 2021 | 238 | 238 | $13,790 | $4,232 | 30.7% |
About Dr. Scott Lawrence, MD
Dr. Scott Lawrence, MD is a Family Medicine healthcare provider based in Detroit Lakes, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1407874076.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Lawrence, MD has received a total of $250.87 in payments from pharmaceutical and medical device companies, with $48.26 received in 2024. These payments were reported across 16 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($250.87).
As a Medicare-enrolled provider, Lawrence has provided services to 2,670 Medicare beneficiaries, totaling 4,541 services with total Medicare billing of $241,019. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Detroit Lakes, MN
- Active Since 07/18/2006
- Last Updated 02/23/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1407874076
Products in Payments
- BREZTRI (Drug) $41.77
- XARELTO (Drug) $24.39
- SOLIQUA 100/33 (Biological) $22.22
- WAKIX (Drug) $20.43
- AIRSUPRA (Drug) $16.87
- Myrbetriq (Drug) $15.34
- Kerendia (Drug) $15.04
- LEQVIO (Drug) $15.00
- Veozah (Drug) $14.50
- STEGLATRO (Drug) $14.02
- Victoza (Drug) $13.73
- Otezla (Drug) $13.07
- BELSOMRA (Drug) $12.96
- Ozempic (Drug) $11.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Detroit Lakes
Jon Larson, Md, MD
Family Medicine — Payments: $223.82
Julie Larson, Md, MD
Family Medicine — Payments: $127.97
Molly Anderson, M.d, M.D
Family Medicine — Payments: $74.23
Joshua Fisher
Family Medicine — Payments: $56.32
Nicole Strand, Md, MD
Family Medicine — Payments: $40.50
Dr. Gaurav Mehta, M.d, M.D
Family Medicine — Payments: $27.42